Skip to content

Taxes Paid at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.63B-2.6%
Regenxbio logo
RegenxbioRGNX
$71.25K+496%
Xencor logo
XencorXNCR
$3.01M
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$2.97M
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$551K-1,120%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Immix Biopharma, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s taxes paid?
Immix Biopharma, Inc. (IMMX) reported taxes paid of $7.72K in Q3 2025.
How has Immix Biopharma, Inc.'s taxes paid changed year-over-year?
Immix Biopharma, Inc.'s taxes paid decreased by 30.7% year-over-year, from $11.14K to $7.72K.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.